LC-MSMS 101 : Getting Started with Quantitative LC-MSMS in the Diagnostic Laboratory
Location: Montreal 1-2
830
1230
Clinical Proteomics 201 : Clinical Proteomics
Location: Montreal 3
Andy Hoofnagle, MD, PhD University of Washington
Dr. Hoofnagle's laboratory focuses on the precise quantification of recognized protein biomarkers in human plasma using LC-MRM/MS. In addition, they have worked to develop novel assays for the quantification of small molecules in clinical and research settings. His laboratory also studies the role that the systemic inflammation plays in the pathophysiology of obesity, diabetes, and cardiovascular disease.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Grant/Research Support
Waters, Inc.
Christopher Shuford, PhD Labcorp
Chris Shuford, Ph.D., is Associate Vice President and Technical Director for research and development at Laboratory Corporation of America in Burlington, North Carolina. Chris received his B.S. in Chemistry & Physics at Longwood University and obtained his Ph.D. in Bioanalytical Chemistry from North Carolina State University under the tutelage of Professor David Muddiman, where his research focused on applications of nano-flow chromatography for multiplexed peptide quantification using protein cleavage coupled with isotope dilution mass spectrometry (PC-IDMS). In 2012, Chris joined LabCorp’s research and development team where his efforts have focused on development of high-flow chromatographic methods (>1 mL/min) for multiplexed and single protein assays for clinical diagnostics.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Stock/Bonds
Laboratory Corporation of America
Salary
Laboratory Corporation of America
830
1230
LC-MSMS 203 : Validation of Quantitative LC-MS/MS Assays for Clinical and Academic Use
Location: Montreal 5
Claire Knezevic, PhD Lurie Childrens Hospital
Dr. Claire Knezevic is a clinical chemist in the Department of Pathology and Laboratory Medicine at Lurie Children's Hospital with a focus on chemistry, point-of-care testing, quality improvement, drug monitoring, and personalized medicine. She is an Associate Professor in Northwestern's Feinberg School of Medicine in the Department of Pathology. Her interests include all things small molecule, from toxicology to therapeutic drug monitoring and their impacts on clinical care.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 06, 2026)
No relevant financial relationship(s) to disclose.
Joshua Hayden, PhD, DABCC, FACB Cleveland Clinic
Joshua is currently the Section Head of Clinical Biochemistry at Cleveland Clinic. He earned his PhD in chemistry from Carnegie Mellon University. He conducted postdoctoral research at Massachusetts Institute of Technology before completing a two-year clinical chemistry fellowship at University of Washington and 4 years as Assistant Professor at Weill Medical College. Joshua has special expertise developing and overseeing mass spectrometry assays in the clinical laboratory.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Honorarium/Expenses
Thermo (speaker)
Committee/Board/Advisory Board
BioPorto (ended)
830
1230
LC-MSMS 302 : Advanced LC-MSMS Method Development, Troubleshooting and Operation for Clinical Analysis
Location: Montreal 6-8
830
1230
Glyco(proteo)mics 101 : Clinical Glyco(proteo)mics by Mass Spectrometry
Location: Westmount 5
Guinevere Lageveen-Kammeijer, PhD University of Groningen
Dr. Guinevere Lageveen-Kammeijer is an Assistant Professor in the Analytical Biochemistry group at the University of Groningen, within the Groningen Research Institute of Pharmacy. She holds a BSc in Biotechnology - Forensic Sciences from the University of Applied Sciences van Hall Larenstein, Leeuwarden, and an MSc in Analytical Chemistry from VU University, Amsterdam. Her research interests were ignited during her MSc internship, where she focused on separation techniques coupled with mass spectrometry.
Guinevere earned her PhD in Clinical Glycomics from the Leiden University Medical Center in 2019 under the supervision of Prof. Manfred Wuhrer. Her thesis developed small-scale sample preparation workflows using capillary electrophoresis (CE) and mass spectrometry (MS/MS) to analyze glycans, glycopeptides, and glycoproteins, with applications in biomarker discovery and biopharmaceutical characterization. She continued her research as a post-doctoral researcher at the same institution before expanding her expertise with a visit to Northeastern University, Boston, in 2017, where she focused on protein charge and proteoform heterogeneity.
In 2022, Guinevere began her tenure-track assistant professorship at the University of Groningen, where she works on advancing glyco(proteo)mic techniques, particularly in single-cell glycomic analysis. Her research includes expanding the mass spectrometry-based glycosylation assay for prostate-specific antigen (PSA), a key biomarker for prostate cancer, and exploring the in-depth analysis of glycans and glycoproteins for biomarker discovery in other diseases and biopharmaceutical characterization.
Guinevere’s contributions have been recognized through funding such as the Investigator Sponsored Research grant from Astellas (2019) and the prestigious NWO VENI grant (2023). She is actively involved in the scientific community, serving on the Scientific Omics Committee for MSACL. Guinevere is passionate about promoting the importance of glycosylation in biomarker research, aiming to bridge the gap between researchers and clinical professionals to improve biomarker translation to the clinic.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 18, 2025)
No relevant financial relationship(s) to disclose.
830
1230
Data Science 203 : Machine Learning : A Gentle Introduction
Location: Outremont 4
830
1230
Data Science 101 : Breaking Up with Excel : An Introduction to the R Statistical Programming Language
Location: Outremont 5
830
1230
Automation 201 : Streamlining Clinical Analysis through Efficient Workflow Integration
Location: Outremont 6
Evan McConnell, PhD Labcorp
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Stock/Bonds
Labcorp
Salary
Labcorp
Matthew Campbell, PhD Labcorp
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Salary
Labcorp
830
1230
Clinical Proteomics 202 : MS-based Precision Diagnostics by Molecular Protein Analysis
Location: Outremont 7
1230
1430
Lunch Break
Location: Your Choice
Your choice! This non-MSACL sponsored meal break is your chance to explore the culinary delights within the city of Montreal. MSACL recommendations.
1430
1830
LC-MSMS 101 : Getting Started with Quantitative LC-MSMS in the Diagnostic Laboratory
Location: Montreal 1-2
1430
1830
Clinical Proteomics 201 : Clinical Proteomics
Location: Montreal 3
1430
1830
LC-MSMS 203 : Validation of Quantitative LC-MS/MS Assays for Clinical and Academic Use
Location: Montreal 5
1430
1830
LC-MSMS 302 : Advanced LC-MSMS Method Development, Troubleshooting and Operation for Clinical Analysis
Location: Montreal 6-8
1430
1830
Glyco(proteo)mics 101 : Clinical Glyco(proteo)mics by Mass Spectrometry
Location: Westmount 5
1430
1830
Data Science 100 : Data Literacy
Location: Westmount 6
Shannon Haymond, PhD Northwestern University Feinberg School of Medicine
My lab performs research and clinical testing using mass spectrometry methods, develops new assays, and applies data analytics to enable improved quality and efficiency. My computational pathology efforts are aimed at building the capacity for advanced data analytics in the department through innovations in infrastructure, education, and research to facilitate data-informed decision making for clinical care, operations, and quality assurance.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Committee/Board/Advisory Board
Roche Diagnostics (ended)
Patrick Mathias, MD, PhD University of Washington
Patrick Mathias, M.D., Ph.D., is a board-certified clinical pathologist and Associate Director of Informatics for UW Laboratory Medicine.
Lab medicine has large impact on the general practice of medicine. It is key to correctly diagnosing diseases and selecting the right treatments for patients. Dr. Mathias's goal is to combine technical and medical knowledge to fulfill the triple aim--reduce the per capita cost of health care, improve the health of populations and most importantly improve the patient experience of care.
Dr. Mathias earned his M.D. and Ph.D. from the University of Illinois. His clinical and research interests include clinical informatics, clinical chemistry and molecular diagnostics.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Stock/Bonds
Amgen, Corcept Therapeutics, Monte Rosa Therapeutics
1430
1830
Lipidomics 101 : Mass Spectrometry-based Lipidomics and Clinical Applications
Location: Outremont 1
Anne K. Bendt, PhD Singapore Lipidomics Incubator (SLING), National University of Singapore
Anne K Bendt studied Biology focusing on marine biotechnology (Greifswald University, Germany), followed by a PhD in Biochemistry (Cologne University, Germany) employing proteomics and transcriptomics. Driven by her fascination for infectious diseases, she joined the National University of Singapore (NUS) in 2004 to develop lipidomics tools for tuberculosis studies. She is now a Principal Investigator at the Life Sciences Institute, NUS, focussing on translation of mass spec technologies into clinical applications, and serving as the Deputy Director of the Singapore Lipidomics Incubator (SLING) taking care of operations and commercialization.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 05, 2026)
No relevant financial relationship(s) to disclose.
Amaury Cazenave Gassiot, PhD Singapore Lipidomics Incubator (SLING) and Department of Biochemistry, National University of Singapore
Research Assistant Prof. Cazenave-Gassiot is an early-career researcher and an expert in mass spectrometry-based lipidomics. He graduated with a PhD in analytical chemistry at the University of Southampton (UK), under the supervision of Dr John Langley, specialising in supercritical fluid chromatography and mass spectrometry. His interest in lipids started while a postdoc in the team of Professor Anthony Postle, still in Southampton. A member of SLING since 2009, his research centres on separation sciences, mass spectrometry, and their applications to life sciences, especially lipid biochemistry. He has developed chromatographic and mass spectrometric methods for the identification and quantification of lipids in diverse biological systems. This has included successful local and international collaborations.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 05, 2026)
No relevant financial relationship(s) to disclose.
Michael Chen, MD MSc The University of British Columbia
Dr. Michael Chen is a clinical pathologist, specializing in clinical chemistry and translational mass spectrometry. He is the Department Head and Medical Director of Laboratory Medicine, Pathology and Medical Genetics at Island Health, and Provincial Discipline Lead at Provincial Health Services Authority. As a researcher, Dr Chen is the scientific director of UBC Translational Omics Lab in the Victoria General Hospital. He is also the director of Vancouver Island Biobank, and he co-chairs the BC Biobank Network. Dr. Chen’s research focuses on clinical mass spectrometry, biobanking, biomarker validation and clinical implementation.
Relevant Financial Disclosures
(within past 24 months, reported on Apr 18, 2026)
Ownership Interest
Pataigin Inc
1430
1830
Data Science 203 : Machine Learning : A Gentle Introduction
Location: Outremont 4
1430
1830
Data Science 101 : Breaking Up with Excel : An Introduction to the R Statistical Programming Language
Location: Outremont 5
1430
1830
Automation 201 : Streamlining Clinical Analysis through Efficient Workflow Integration
Location: Outremont 6
1430
1830
Isotopes 101 : Modern Isotope Ratio Analysis for Biomedical Research and Clinical Diagnostics
Location: Outremont 7
Cajetan Neubauer University of Colorado, Boulder
The frontiers of metabolomics & proteomics are finally merging with isotope ratio mass spectrometry, opening exciting new opportunities in our understanding of biological systems.
My lab at the University of Colorado Boulder helps pioneer related novel molecular measurements based on soft-ionization isotope ratio mass spectrometry. These advances can be used to study natural stable isotope fingerprints in metabolites, drugs, or small inorganic ions for a fascinating range of cross-disciplinary applications in life and earth sciences.
To achieve our longterm goal of making natural isotope patterns universally useful, we combine expertise in metabolomics and proteomics with advanced concepts of high precision stable isotope analysis from geochemistry.
Relevant Financial Disclosures
(within past 24 months, reported on Jan 14, 2026)
No relevant financial relationship(s) to disclose.
Dwight Matthews, Ph.D. University of Vermont
Prof. Matthews received his PhD degree in 1977 in Analytical Chemistry from Indiana University with a focus in mass spectrometry. For his Ph.D. thesis he developed the first gas chromatograph-combustion-isotope ratio mass spectrometer (GC-C-IRMS). He then began his career at Washington University School of Medicine in St. Louis in the Department of Medicine where he developed stable isotope tracer methods to study in vivo amino acid metabolism in humans centered around gas chromatography-mass spectrometry (GC-MS). Several of these methods are commonly used by investigators today. In 1986 he moved to Cornell University Medical College in New York City as a tenured Associate Professor of Biochemistry in Medicine and Surgery to continue studies of metabolism. Here his focus broadened to include studies of metabolism in conditions found commonly in surgical metabolism and energy metabolism using doubly labeled water measured by IRMS. He also directed the Core Laboratories of the General Clinical Research Center. In 1996 he moved to the University of Vermont (UVM) as a Professor of Medicine in the College of Medicine and as a Professor of Chemistry in the College of Arts and Sciences. At UVM he directed core laboratories related to mass spectrometry for the Clinical Research Center, the Vermont Genetics Network Proteomics Core Laboratory, and the Mass Spectrometry Core Laboratory in Immunobiology. During this period, he developed new proteomics methods using liquid chromatography-mass spectrometry (LC-MS) with a focus on precise measurement of stable isotopic enrichments in proteins and peptides. From 2002-2014, he was Chair of the Department of Chemistry at UVM and named the Pomeroy Professor of Chemistry. In 2019, Matthews became a Professor Emeritus of Chemistry and Medicine at UVM, but continues his research activities. Professor Matthews is a world-renown expert in the development of stable isotope tracer techniques to study metabolism in humans. He has published over 175 papers in a range of peer-reviewed journals and over 75 contributions to symposia and chapters in books, and has an H-index of 85.
Relevant Financial Disclosures
(within past 24 months, reported on Jan 14, 2026)
No relevant financial relationship(s) to disclose.
Bruce Buchholz, Ph.D. Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory
Dr. Bruce Buchholz is a senior scientist at the Center for Accelerator Mass Spectrometry at LLNL and the Project Manager for the NIH User Resource for Biological Accelerator Mass Spectrometry (BioAMS). For the past 25 years he has designed and conducted 14C-tracer biological AMS studies with collaborators around the world in the fields of nutrition, environmental toxicology, cancer biology, pesticide ADME, and cell biology. His academic training is in physics and he holds a Ph.D. in Nuclear Engineering from the University of Illinois. Before joining LLNL he completed postdocs at Argonne National Laboratory in nuclear-chemical engineering and at UC Davis in pesticide ADME in the Department of Entomology. He has authored more than 100 peer-reviewed publications on the use of isotopic tracers in biology, combustion systems, and chemical engineering.
Relevant Financial Disclosures
(within past 24 months, reported on Jul 14, 2025)
Other Potential Conflicts
Amgen / Stock
Patrick Day, MPH, MLS (ASCP) Mayo Clinic
My background, training, and educational degrees are in Laboratory Medicine & Pathology and Public Health. I received my bachelor’s and master’s degrees both from the University of Minnesota. My MPH thesis was on how geospatial supercomputing and clinical laboratory data can be combined to study how socioeconomic determinants of health and geography within the United States are associated with elevated levels of arsenic and mercury in humans. I am currently a principal developer in the Division of Computational Pathology and Artificial Intelligence at the Mayo Clinic in Rochester, MN. Prior to this role, I was a senior developer with the Metals Laboratory at Mayo Clinic. This clinical laboratory is staffed by thirty highly specialized employees that conduct metal analysis of biologic samples as well as analyze thousands of kidney stones a year by Fourier Transform Infrared Spectroscopy (FTIR). In the Metals Laboratory, I developed numerous laboratory developed tests (LDTs) as well as managed various multidisciplinary research projects. I currently hold the academic rank of Instructor in the Mayo Clinic College of Medicine and Science. I have co-authored numerous conference abstracts and peer-reviewed articles related to metals toxicology and artificial intelligence in the clinical laboratory and was honored to receive an American Society for Clinical Pathology 40 under Forty award.
Relevant Financial Disclosures
(within past 24 months, reported on Jan 21, 2025)
No relevant financial relationship(s) to disclose.
1830
1900
Happy Half-Hour!
Location: Foyer, Conference Level
Open to all conference registrants. Use this time to finalize dinner plans with fellow attendees.
1900
2100
Dinner
Location: Your Choice
Your choice! This non-MSACL sponsored meal break is your chance to explore the culinary delights within the city of Montreal. MSACL recommendations.
2100
2330
MSACL Hospitality Lounge
Location: Salon Ville-Marie, Hotel Level
All attendees are welcome to close out the evening in Salon Ville Marie. MSACL will host drinks and snacks. The evening will include a live jazz duo from 9-10pm. Enjoy the hotel's 2.5 acres of gardens outside on the adjoining patio.
